Skip to main content
Top
Published in: Clinical and Experimental Nephrology 3/2017

01-06-2017 | Original article

Diuretics prescribing in chronic kidney disease patients: physician assessment versus bioimpedence spectroscopy

Authors: Yusra Habib Khan, Azmi Sarriff, Azreen Syazril Adnan, Amer Hayat Khan, Tauqeer Hussain Mallhi

Published in: Clinical and Experimental Nephrology | Issue 3/2017

Login to get access

Abstract

Introduction

The relationship between hypertension and fluid overload in pre-dialysis CKD patients need to be elucidated. Current study aimed to find relationship between fluid overload and hypertension along with prescribed diuretic therapy using bioimpedance spectroscopy (BIS).

Methodology

A prospective observational study was conducted by inviting pre-dialysis CKD patients. Fluid overload was assessed by BIS.

Results

A total of 312 CKD patients with mean eGFR 24.5 ± 11.2 ml/min/1.73 m2 were enrolled. Based on OH value ≥7 %, 135 (43.3 %) patients were hypervolemic while euvolemia was observed in 177 (56.7 %) patients. Patients were categorized in different regions of hydration reference plot (HRP) generated by BIS i.e., 5.1 % in region-N (normal BP and fluid status), 20.5 % in region I (hypertensive with severe fluid overload), 29.5 % in region I–II (hypertensive with mild fluid overload), 22 % in region II (hypertensive with normohydration), 10.2 % in region III (underhydration with normal/low BP) and 12.5 % in region IV (normal BP with severe fluid overload). A total of 144 (46 %) patients received diuretics on basis of physician assessment of BP and edema. Maximum diuretics 100 (69.4 %) were prescribed in patients belonging to regions I and I–II of HRP. Interestingly, a similar number of diuretic prescriptions were observed in region II (13 %) and region IV (12 %). Surprisingly, 7 (4.9 %) of patients in region III who were neither hypervolemic nor hypertensive were also prescribed with diuretics.

Conclusion

BIS can aid clinicians to categorize CKD patients on basis of their fluid status and provide individualized pharmacotherapy to manage hypertensive CKD patients.
Literature
1.
go back to reference El Nahas AM, Bello AK. Chronic kidney disease: the global challenge. Lancet. 2005;365(9456):331–40.CrossRef El Nahas AM, Bello AK. Chronic kidney disease: the global challenge. Lancet. 2005;365(9456):331–40.CrossRef
2.
3.
go back to reference Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, Parfrey P. Kidney disease as a risk factor for development of cardiovascular disease a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003;108(17):2154–69.CrossRefPubMed Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, Parfrey P. Kidney disease as a risk factor for development of cardiovascular disease a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003;108(17):2154–69.CrossRefPubMed
4.
go back to reference Wizemann V, Schilling M. Dilemma of assessing volume state—the use and the limitations of a clinical score. Nephrol Dial Transpl. 1995;10(11):2114–7. Wizemann V, Schilling M. Dilemma of assessing volume state—the use and the limitations of a clinical score. Nephrol Dial Transpl. 1995;10(11):2114–7.
5.
go back to reference Wabel P, Moissl U, Chamney P, Jirka T, Machek P, Ponce P, Zaluska W. Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transpl. 2008;23(9):2965–71.CrossRef Wabel P, Moissl U, Chamney P, Jirka T, Machek P, Ponce P, Zaluska W. Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transpl. 2008;23(9):2965–71.CrossRef
6.
go back to reference Desai AS, Toto R, Jarolim P, Uno H, Eckardt KU, Kewalramani R, Solomon SD. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD. Am J Kidney Dis. 2011;58(5):717–28.CrossRefPubMed Desai AS, Toto R, Jarolim P, Uno H, Eckardt KU, Kewalramani R, Solomon SD. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD. Am J Kidney Dis. 2011;58(5):717–28.CrossRefPubMed
7.
go back to reference Yilmaz Z, Yildirim Y, Oto F, Aydin FY, Aydin E, Kadiroglu AK, Yilmaz ME. Evaluation of volume overload by bioelectrical impedance analysis, NT-proBNP and inferior vena cava diameter in patients with stage 3&4 and 5 chronic kidney disease. Ren Fail. 2014;36(4):495–501.CrossRefPubMed Yilmaz Z, Yildirim Y, Oto F, Aydin FY, Aydin E, Kadiroglu AK, Yilmaz ME. Evaluation of volume overload by bioelectrical impedance analysis, NT-proBNP and inferior vena cava diameter in patients with stage 3&4 and 5 chronic kidney disease. Ren Fail. 2014;36(4):495–501.CrossRefPubMed
8.
go back to reference Tsai YC, Tsai JC, Chiu YW, Kuo HT, Chen SC, Hwang SJ, Chen HC. Is fluid overload more important than diabetes in renal progression in late chronic kidney disease? PLoS One. 2013;8(12):e82566.CrossRefPubMedPubMedCentral Tsai YC, Tsai JC, Chiu YW, Kuo HT, Chen SC, Hwang SJ, Chen HC. Is fluid overload more important than diabetes in renal progression in late chronic kidney disease? PLoS One. 2013;8(12):e82566.CrossRefPubMedPubMedCentral
9.
go back to reference Hung SC, Kuo KL, Peng CH, Wu CH, Wang YC, Tarng DC. Association of fluid retention with anemia and clinical outcomes among patients with chronic kidney disease. J Am Heart Assoc. 2015;4(1):e001480.CrossRefPubMedPubMedCentral Hung SC, Kuo KL, Peng CH, Wu CH, Wang YC, Tarng DC. Association of fluid retention with anemia and clinical outcomes among patients with chronic kidney disease. J Am Heart Assoc. 2015;4(1):e001480.CrossRefPubMedPubMedCentral
10.
go back to reference Charra B. Fluid balance, dry weight, and blood pressure in dialysis. Hemodial Int. 2007;11(1):21–31.CrossRefPubMed Charra B. Fluid balance, dry weight, and blood pressure in dialysis. Hemodial Int. 2007;11(1):21–31.CrossRefPubMed
11.
go back to reference Kooman JP, van der Sande FM, Leunissen KM. Role of sodium and volume in the pathogenesis of hypertension in dialysis patients. Blood Purif. 2004;22(1):55–9.CrossRefPubMed Kooman JP, van der Sande FM, Leunissen KM. Role of sodium and volume in the pathogenesis of hypertension in dialysis patients. Blood Purif. 2004;22(1):55–9.CrossRefPubMed
12.
go back to reference Levin A, Stevens PE. Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 2014;85(1):49–61.CrossRefPubMed Levin A, Stevens PE. Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 2014;85(1):49–61.CrossRefPubMed
13.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Coresh J. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Coresh J. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRefPubMedPubMedCentral
14.
go back to reference Wizemann V, Rode C, Wabel P. Whole-body spectroscopy (BCM) in the assessment of normovolemia in hemodialysis patients. In: Hemodialysis-From basic research to clinical trials. 2008. Vol. 161, pp. 115–118. Wizemann V, Rode C, Wabel P. Whole-body spectroscopy (BCM) in the assessment of normovolemia in hemodialysis patients. In: Hemodialysis-From basic research to clinical trials. 2008. Vol. 161, pp. 115–118.
15.
go back to reference Moissl UM, Wabel P, Chamney PW, Bosaeus I, Levin NW, Bosy-Westphal A, Kaitwatcharachai C. Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas. 2006;27(9):921.CrossRefPubMed Moissl UM, Wabel P, Chamney PW, Bosaeus I, Levin NW, Bosy-Westphal A, Kaitwatcharachai C. Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas. 2006;27(9):921.CrossRefPubMed
16.
go back to reference Wieskotten S, Heinke S, Wabel P, Moissl U, Becker J, Pirlich M, Isermann R. Bioimpedance-based identification of malnutrition using fuzzy logic. Physiol Meas. 2008;29(5):639.CrossRefPubMed Wieskotten S, Heinke S, Wabel P, Moissl U, Becker J, Pirlich M, Isermann R. Bioimpedance-based identification of malnutrition using fuzzy logic. Physiol Meas. 2008;29(5):639.CrossRefPubMed
17.
go back to reference Jones DW, Hall JE. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure and evidence from new hypertension trials. Hypertension. 2004;43(1):1–3.CrossRefPubMed Jones DW, Hall JE. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure and evidence from new hypertension trials. Hypertension. 2004;43(1):1–3.CrossRefPubMed
18.
go back to reference Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21(6):1011–53.CrossRef Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21(6):1011–53.CrossRef
19.
go back to reference De Nicola L, Minutolo R, Zamboli P, Cestaro R, Marzano L, Giannattasio P, Rapisarda F. Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study. In: Seminars in nephrology. WB Saunders; 2005. Vol. 25, no. 6, pp. 425–430. De Nicola L, Minutolo R, Zamboli P, Cestaro R, Marzano L, Giannattasio P, Rapisarda F. Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study. In: Seminars in nephrology. WB Saunders; 2005. Vol. 25, no. 6, pp. 425–430.
20.
go back to reference Tsai YC, Tsai JC, Chen SC, Chiu YW, Hwang SJ, Hung CC, Chen HC. Association of fluid overload with kidney disease progression in advanced CKD: a prospective cohort study. Am J Kidney Dis. 2014;63(1):68–75.CrossRefPubMed Tsai YC, Tsai JC, Chen SC, Chiu YW, Hwang SJ, Hung CC, Chen HC. Association of fluid overload with kidney disease progression in advanced CKD: a prospective cohort study. Am J Kidney Dis. 2014;63(1):68–75.CrossRefPubMed
21.
go back to reference Wang W, Lee ET, Fabsitz RR, Devereux R, Best L, Welty TK, Howard BV. A longitudinal study of hypertension risk factors and their relation to cardiovascular disease the strong heart study. Hypertension. 2006;47(3):403–9.CrossRefPubMed Wang W, Lee ET, Fabsitz RR, Devereux R, Best L, Welty TK, Howard BV. A longitudinal study of hypertension risk factors and their relation to cardiovascular disease the strong heart study. Hypertension. 2006;47(3):403–9.CrossRefPubMed
22.
go back to reference Di Loreto V, Moreno HS, Puche RC, Locatto ME. Severe hyperglycemia: a determinant factor for hypofiltration in alloxan diabetic rats. Acta Diabetol. 2004;41(2):56–62.CrossRefPubMed Di Loreto V, Moreno HS, Puche RC, Locatto ME. Severe hyperglycemia: a determinant factor for hypofiltration in alloxan diabetic rats. Acta Diabetol. 2004;41(2):56–62.CrossRefPubMed
23.
go back to reference Shurraw S, Hemmelgarn B, Lin M, Majumdar SR, Klarenbach S, Manns B, Alberta Kidney Disease Network. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med. 2011;171(21):1920–7.CrossRefPubMed Shurraw S, Hemmelgarn B, Lin M, Majumdar SR, Klarenbach S, Manns B, Alberta Kidney Disease Network. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med. 2011;171(21):1920–7.CrossRefPubMed
24.
go back to reference Essig M, Escoubet B, de Zuttere D, Blanchet F, Arnoult F, Dupuis E, Vrtovsnik F. Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease. Nephrol Dial Transpl. 2008;23(1):239–48.CrossRef Essig M, Escoubet B, de Zuttere D, Blanchet F, Arnoult F, Dupuis E, Vrtovsnik F. Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease. Nephrol Dial Transpl. 2008;23(1):239–48.CrossRef
25.
go back to reference Jones CH, Akbani H, Croft DC, Worth DP. The relationship between serum albumin and hydration status in hemodialysis patients. J Renal Nutr. 2002;12(4):209–12.CrossRef Jones CH, Akbani H, Croft DC, Worth DP. The relationship between serum albumin and hydration status in hemodialysis patients. J Renal Nutr. 2002;12(4):209–12.CrossRef
Metadata
Title
Diuretics prescribing in chronic kidney disease patients: physician assessment versus bioimpedence spectroscopy
Authors
Yusra Habib Khan
Azmi Sarriff
Azreen Syazril Adnan
Amer Hayat Khan
Tauqeer Hussain Mallhi
Publication date
01-06-2017
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 3/2017
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-016-1303-7

Other articles of this Issue 3/2017

Clinical and Experimental Nephrology 3/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.